Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Interest & Investment Income (2023 - 2025)

Aethlon Medical filings provide 6 years of Interest & Investment Income readings, the most recent being $93916.0 for Q1 2025.

  • On a quarterly basis, Interest & Investment Income rose 18.11% to $93916.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $298444.0, a 33.29% decrease, with the full-year FY2025 number at $298122.0, down 33.36% from a year prior.
  • Interest & Investment Income hit $93916.0 in Q1 2025 for Aethlon Medical, up from $59964.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $140890.0 in Q3 2023 to a low of $10973.0 in Q1 2023.
  • Median Interest & Investment Income over the past 3 years was $93916.0 (2025), compared with a mean of $84085.9.
  • The widest YoY moves for Interest & Investment Income: up 624.67% in 2024, down 60.77% in 2024.
  • Aethlon Medical's Interest & Investment Income stood at $100967.0 in 2023, then plummeted by 40.61% to $59964.0 in 2024, then skyrocketed by 56.62% to $93916.0 in 2025.
  • The last three reported values for Interest & Investment Income were $93916.0 (Q1 2025), $59964.0 (Q4 2024), and $95146.0 (Q3 2024) per Business Quant data.